NCT00602134View on ClinicalTrials.gov

Bioequivalence Study of 6-Mercaptopurine Under Fasting Conditions

NACompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

November 30, 2002

Primary Completion Date

November 30, 2002

Study Completion Date

November 30, 2002

Conditions
Acute Lymphoblastic Leukemia
Interventions
DRUG

6-Mercaptopurine

Trial Locations (1)

85044

MDS Pharma Services, Phoenix

All Listed Sponsors
lead

Roxane Laboratories

INDUSTRY

NCT00602134 - Bioequivalence Study of 6-Mercaptopurine Under Fasting Conditions | Biotech Hunter | Biotech Hunter